Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance

NCT04584411 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-10-14

No results posted yet for this study

Summary

Detection of the incidence and types of arrhythmia and conduction block in COVID - 19 patients Detection and description of CMR patterns of myocardial injury in COVID-19 patients with arrhythmias.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Cardiac Magnetic resonance imaging

The following basic sequences will be conducted: * Cine imaging using SSFP sequence for cardiac structure and function. * Tissue characterization imaging, T1 and T2. * Myocardial perfusion imaging. * Late gadolinium enhancement. Diagnosis of myocarditis will be based on the modified Lake Louise criteria: T2-weighted: any of the following standard T2 sequences: regional high signal standard T2 sequences: global signal intensity ratio (myocardium/skeletal muscle) ≥2 T2 mapping: increased T2 relaxation times T1-weighted: any of the following late enhancement imaging: non-ischemic (subepicardial or mid myocardial) late enhancement native T1 mapping: increased T1 relaxation times or extracellular volume supportive criteria: signs of pericarditis: effusion or pericardial late enhancement regional or global wall motion abnormalities\[5\]

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Doaa A Fouad, Doctorate · Assiut University

  • Alaa A El-Moniem, Doctorate · Assiut University

  • Mohamed A.H Abdelhafez, Doctorate · Assiut University

  • Shimaa S Khider, Doctorate · Assiut University

  • Ahmed AR Hassaan, bachelor · Assiut University

  • Maram M Shafiq, student · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-11-01
Completion
2024-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584411 on ClinicalTrials.gov